BIESF Biotest Aktiengesellschaft

USD 30.48 0.00 0
Icon

Biotest Aktiengesellschaft (BIESF) Stock Analysis and Price Targets

COMMON STOCK | | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 30.48

0.00 (0.00)%

USD 0.99B

N/A

N/A

N/A

Icon

BIESF

Biotest Aktiengesellschaft (USD)
COMMON STOCK | OTC
USD 30.48
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.99B

N/A

USD 30.48

Biotest Aktiengesellschaft (BIESF) Stock Forecast

N/A

Based on the Biotest Aktiengesellschaft stock forecast from 0 analysts, the average analyst target price for Biotest Aktiengesellschaft is not available over the next 12 months. Biotest Aktiengesellschaft’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Biotest Aktiengesellschaft is Neutral, which is based on 1 positive signals and 1 negative signals. At the last closing, Biotest Aktiengesellschaft’s stock price was USD 30.48. Biotest Aktiengesellschaft’s stock price has changed by +0.00% over the past week, +0.00% over the past month and -26.47% over the last year.

No recent analyst target price found for Biotest Aktiengesellschaft
No recent average analyst rating found for Biotest Aktiengesellschaft

Company Overview Biotest Aktiengesellschaft

Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in haematology, clinical immuno...Read More

N/A

N/A

1,663

N/A

USD

USA

Adjusted Closing Price for Biotest Aktiengesellschaft (BIESF)

Loading...

Unadjusted Closing Price for Biotest Aktiengesellschaft (BIESF)

Loading...

Share Trading Volume for Biotest Aktiengesellschaft Shares

Loading...

Compare Performance of Biotest Aktiengesellschaft Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BIESF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Biotest Aktiengesellschaft (Sector: )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NCRRP
NCR Corp Pref A 0.00 (0.00%) USD137.98B 972.26 N/A

ETFs Containing BIESF

Symbol Name BIESF's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Biotest Aktiengesellschaft (BIESF) Stock

Stock Target Advisor's fundamental analysis for Biotest Aktiengesellschaft's stock is Neutral.

Unfortunately we do not have enough data on BIESF's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BIESF's stock to indicate what its average analyst target is.

BIESF stock's Price/Earning ratio is 5.50. Based on this BIESF may be undervalued for its sector.

The last closing price of BIESF's stock was USD 30.48.

The most recent market capitalization for BIESF is USD 0.99B.

Unfortunately we do not have enough analyst data on BIESF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Biotest Aktiengesellschaft's stock.

As per our most recent records Biotest Aktiengesellschaft has 1,663 Employees.

Sorry we do not have any infomation available on Biotest Aktiengesellschaft's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...